Search Results - "ÖSTERGREN, J"

Cystatin C—A marker of peripheral atherosclerotic disease? by Arpegård, J, Östergren, J, de Faire, U, Hansson, L.-O, Svensson, P

“…Abstract It has been suggested that Cystatin C, besides its function as a marker of glomerular filtration, could be an independent marker of cardiovascular…”
Get full text

High variability in spawning migration of sea trout, Salmo trutta, in two northern Swedish rivers by ÖSTERGREN, J, LUNDQVIST, H, NILSSON, J

“…Abstract Telemetry was used to examine spawning migration of sea trout, Salmo trutta L. (n = 126), in two rivers in northern Sweden. The spawning areas defined…”
Get full text

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease by Östergren, J., Sleight, P., Dagenais, G., Danisa, K., Bosch, J., Qilong, Yi, Yusuf, S.

“…Aims The aim of this study was to assess the prognostic importance of peripheral arterial disease (PAD) as evaluated by ankle blood pressure index (ABI), and…”
Get full text

Trade-offs among spatio-temporal management actions for a mixed-stock fishery revealed by Bayesian decision analysis by Whitlock, R E, Pakarinen, T, Palm, S, Koljonen, M L, Östergren, J, Dannewitz, J

“…Abstract Management and conservation of populations that are harvested simultaneously present a unique set of challenges. Failure to account for differences in…”
Get full text

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure by HILLEGE, Hans L, NITSCH, Dorothea, DE ZEEUW, Dick, POCOCK, Stuart, VAN VELDHUISEN, Dirk J, PFEFFER, Marc A, SWEDBERG, Karl, MCMURRAY, John J. V, YUSUF, Salim, GRANGER, Christopher B, MICHELSON, Eric L, ÖSTERGREN, Jan, CORNEL, Jan Hein

“…Decreased renal function has been found to be an independent risk factor for cardiovascular outcomes in patients with chronic heart failure (CHF) with markedly…”
Get full text

Predictors of mortality and morbidity in patients with chronic heart failure by Pocock, Stuart J., Wang, Duolao, Pfeffer, Marc A., Yusuf, Salim, McMurray, John J.V., Swedberg, Karl B., Östergren, Jan, Michelson, Eric L., Pieper, Karen S., Granger, Christopher B.

“…Aims We aimed to develop prognostic models for patients with chronic heart failure (CHF). Methods and results We evaluated data from 7599 patients in the CHARM…”
Get full text

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial by McMurray, John JV, Östergren, Jan, Swedberg, Karl, Granger, Christopher B, Held, Peter, Michelson, Eric L, Olofsson, Bertil, Yusuf, Salim, Pfeffer, Marc A

“…Angiotensin II type 1 receptor blockers have favourable effects on haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when…”
Get full text

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial by Granger, Christopher B, McMurray, John JV, Yusuf, Salim, Held, Peter, Michelson, Eric L, Olofsson, Bertil, Östergren, Jan, Pfeffer, Marc A, Swedberg, Karl

“…Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients with chronic heart failure (CHF). A substantial proportion of patients, however,…”
Get full text

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved by Rogers, Jennifer K., Pocock, Stuart J., McMurray, John J.V., Granger, Christopher B., Michelson, Eric L., Östergren, Jan, Pfeffer, Marc A., Solomon, Scott D., Swedberg, Karl, Yusuf, Salim

“…Aims Heart failure is characterized by recurrent hospitalizations, but often only the first event is considered in clinical trial reports. In chronic diseases,…”
Get full text

Influence of European sculpin, Cottus gobio, on Atlantic salmon Salmo salar, recruitment and the effect of gravel size on egg predation - implications for spawning habitat restoration by PALM, D, LINDBERG, M, BRÄNNÄS, E, LUNDQVIST, H, ÖSTERGREN, J, CARLSSON, U

“…The study examined if recruitment of juvenile Atlantic salmon, Salmo salar L., was influenced by the presence of European sculpin, Cottus gobio L., and if the…”
Get full text

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial by Dahlöf, Björn, Sever, Peter S, Poulter, Neil R, Wedel, Hans, Beevers, D Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Östergren, Jan

“…The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics…”
Get full text

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial by Yusuf, Salim, Pfeffer, Marc A, Swedberg, Karl, Granger, Christopher B, Held, Peter, McMurray, John JV, Michelson, Eric L, Olofsson, Bertil, Östergren, Jan

“…Half of patients with chronic heart failure (CHF) have preserved left-ventricular ejection fraction (LVEF), but few treatments have specifically been assessed…”
Get full text

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme by Pfeffer, Marc A, Swedberg, Karl, Granger, Christopher B, Held, Peter, McMurray, John JV, Michelson, Eric L, Olofsson, Bertil, Östergren, Jan, Yusuf, Salim

“…Patients with chronic heart failure (CHF) are at high risk of cardiovascular death and recurrent hospital admissions. We aimed to find out whether the use of…”
Get full text

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme by MacDonald, Michael R, Petrie, Mark C, Varyani, Fumi, Ostergren, Jan, Michelson, Eric L, Young, James B, Solomon, Scott D, Granger, Christopher B, Swedberg, Karl, Yusuf, Salim, Pfeffer, Marc A, McMurray, John J V

“…To determine whether the risk of adverse cardiovascular (CV) outcomes associated with diabetes differs in patients with low and preserved ejection fraction…”
Get full text

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy by Svensson, Per, de Faire, Ulf, Sleight, Peter, Yusuf, Salim, Östergren, Jan

“…In the HOPE-trial, the ACE inhibitor ramipril significantly reduced cardiovascular morbidity and mortality in patients at high risk for cardiovascular events…”
Get full text

Prognosis in therapy-resistant hypertension by Isaksson, H, Ostergren, J

“…To study the prognosis in therapy-resistant hypertension (RH). Patients with RH and age- and sex-matched responding hypertensives, were followed-up for a…”
Get more information

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program by Ariti, Cono A., MSc, Cleland, John G.F., MD, Pocock, Stuart J., PhD, Pfeffer, Marc A., MD, PhD, Swedberg, Karl, MD, PhD, Granger, Christopher B., MD, McMurray, John J.V., MD, Michelson, Eric L., MD, Östergren, Jan, MD, PhD, Yusuf, Salim, MD, DPhil

“…Background Conventional composite outcomes in heart failure (HF) trials, for example, time to cardiovascular death or first HF hospitalization, have recognized…”
Get full text

Interruptions in emergency department work: an observational and interview study by Berg, Lena M, Källberg, Ann-Sofie, Göransson, Katarina E, Östergren, Jan, Florin, Jan, Ehrenberg, Anna

“…Frequent interruptions are assumed to have a negative effect on healthcare clinicians' working memory that could result in risk for errors and hence…”
Get more information

Influence of statin treatment on platelet inhibition by clopidogrel – a randomized comparison of rosuvastatin, atorvastatin and simvastatin co‐treatment by Malmström, R. E., Östergren, J., Jørgensen, L., Hjemdahl, P.

“… Objectives.  Possible interactions between clopidogrel and atorvastatin, simvastatin or rosuvastatin (a ‘non‐CYP3A4’ metabolized statin) were investigated in…”
Get full text

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program by O'MEARA, Eileen, CLAYTON, Tim, OLOFSSON, Bertil, MICHELSON, Eric L, POCOCK, Stuart, YUSUF, Salim, SWEDBERG, Karl, PFEFFER, Marc A, MCENTEGART, Margaret B, MCMURRAY, John J. V, LANG, Chim C, ROGER, Simon D, YOUNG, James B, SOLOMON, Scott D, GRANGER, Christopher B, ÖSTERGREN, Jan

“…We wished to determine the prevalence of, potential mechanistic associations of, and clinical outcomes related to anemia in patients with heart failure and a…”
Get full text